Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2018 1
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Tanum L, Solli KK, Latif ZE, Benth JŠ, Opheim A, Sharma-Haase K, Krajci P, Kunøe N. Tanum L, et al. Among authors: Solli KK. JAMA Psychiatry. 2017 Dec 1;74(12):1197-1205. doi: 10.1001/jamapsychiatry.2017.3206. JAMA Psychiatry. 2017. PMID: 29049469 Free PMC article. Clinical Trial.
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.
Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L. Latif ZE, et al. Among authors: Solli KK. JAMA Psychiatry. 2019 Feb 1;76(2):127-134. doi: 10.1001/jamapsychiatry.2018.3537. JAMA Psychiatry. 2019. PMID: 30566177 Free PMC article. Clinical Trial.
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).
Kunøe N, Opheim A, Solli KK, Gaulen Z, Sharma-Haase K, Latif ZE, Tanum L. Kunøe N, et al. Among authors: Solli KK. BMC Pharmacol Toxicol. 2016 Apr 28;17(1):18. doi: 10.1186/s40360-016-0061-1. BMC Pharmacol Toxicol. 2016. PMID: 27121539 Free PMC article. Clinical Trial.
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.
Latif ZE, Solli KK, Opheim A, Kunoe N, Benth JŠ, Krajci P, Sharma-Haase K, Tanum L. Latif ZE, et al. Among authors: Solli KK. Am J Addict. 2019 Feb;28(2):77-85. doi: 10.1111/ajad.12859. Epub 2019 Jan 31. Am J Addict. 2019. PMID: 30701613 Clinical Trial.
Interest in Extended Release Naltrexone among Opioid Users.
Sharma Haase K, Kunøe N, Opheim A, Gaulen Z, Njå AM, Latif ZE, Solli KK, Tanum L. Sharma Haase K, et al. Among authors: Solli KK. Eur Addict Res. 2016;22(6):301-305. doi: 10.1159/000447964. Epub 2016 Jul 20. Eur Addict Res. 2016. PMID: 27434137
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial.
Solli KK, Kunoe N, Latif ZE, Sharma-Haase K, Opheim A, Krajci P, Gaulen Z, Šaltytė Benth J, Tanum L. Solli KK, et al. Eur Addict Res. 2019;25(6):303-309. doi: 10.1159/000501931. Epub 2019 Jul 24. Eur Addict Res. 2019. PMID: 31340204 Clinical Trial.
Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care.
Drivenes K, Haaland VØ, Hauge YL, Vederhus JK, Irgens AC, Solli KK, Regevik H, Falk RS, Tanum L. Drivenes K, et al. Among authors: Solli KK. Front Psychol. 2020 Mar 24;11:443. doi: 10.3389/fpsyg.2020.00443. eCollection 2020. Front Psychol. 2020. PMID: 32265780 Free PMC article.